Description: Human longevity is one of the great success stories of the past century, and there is growing consensus that there are further gains to come. What will these future gains look like, where will they come from and how likely are they to happen. Furthermore, how do we as actuaries deal with the uncertainty when trying to predict future long-term mortality improvements more than 20 years into the future. This is one of the most important assumptions on the balance sheet that insurers and reinsurers make, so it is important to have a strong perspective on it. Our presentation will give attendees a view into some of the core components of how to assess long-term mortality improvements by looking at the cyclical nature across different countries of life expectancy. It will also deep dive into the different drivers of life expectancy over the past cycle driven largely by improved diagnosis and treatment of cardiovascular disease (CVD) and cessation of smoking, which ended in about 2010. It will then discuss how population mortality improvement has slowed and plateaued in many major countries.

Description: Statutory and GAAP metrics are useful for external audiences such as regulators and investors since they provide a consistent framework for viewing and comparing multiple companies at a point in time. However, their uses are more limited for managers who require more real-time information in making strategic decisions. Many insurers are developing internal metrics such as Value of New Business (VNB) for better profitability insights at the point of sale, to understand how new business profitability changes over time and to allow for quicker decision making. By leveraging existing models and reporting processes, insurers can reduce the additional effort involved in applying VNB toward applications such as pricing, capital allocation and risk management. Find out more about key considerations for developing and using VNB.

Description: Modifiable risk factors stand out today as significant contributors to diseases, and yet we as an industry haven't tackled this. Instead, we sit by almost passively as obesity, diabetes and hypertension rates continue to skyrocket. In fact, obesity and overweight is now over 70% of the US population and has turned into the forgotten pandemic. Globally, no country in the world has improved their obesity percentage rates during the past 15 years. Insurers are starting to explore health interventions which have the potential to reduce claims and change people's behavior.